Pulmonary Arterial Hypertension: Opsynvi is indicated for the long-term treatment of pulmonary arterial hypertension (PAH) in adults with PAH (WHO FC II or III), who are already treated with macitentan and tadalafil or medications within the same classes, in accordance with the medical practices.